Oaktree Acquisition Corp. III Life Sciences (OACC)
US — Financial Services Sector
Automate Your Wheel Strategy on OACC
With Tiblio's Option Bot, you can configure your own wheel strategy including OACC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol OACC
- Rev/Share 0.0
- Book/Share 7.7712
- PB 1.3524
- Debt/Equity 0.0001
- CurrentRatio 1.3948
- ROIC -0.0054
- MktCap 258364892.0
- FreeCF/Share -0.009
- PFCF -1165.4595
- PE 53.1086
- Debt/Assets 0.0001
- DivYield 0
- ROE 0.0343
- Rating B-
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 3
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
About Oaktree Acquisition Corp. III Life Sciences (OACC)
- IPO Date 2024-12-16
- Website https://www.oaktreeacquisitioncorp.com/oac-iii
- Industry Shell Companies
- CEO Zaid Pardesi
- Employees 3
Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.